Site Map
Pages
- About Us
- Brain-type naturiuretic peptide (BNP) Antibodies
- Careers
- Contact Us
- FACS
- Glucagon Monoclonal Antibodies
- Glycogen Phosphorylase BB (GPBB) Antibodies
- Group A Streptococci (GAS) Antibodies
- Heart-type Fatty Acid Binding Protein (H-FABP) Antibodies
- Home
- News
- Pregnancy-associated plasma protein A (PAPP-A) Antibodies
- Procalcitonin (PCT) Antibodies
- Products
- Request Quote
- Research & Diagnostic Antibodies
- Search
- Services
- Technologies
- Thank You
- Therapeutic Antibodies
News
Company News
- AvantGen awarded contract from NIH to expedite the commercialization of its AccuRate COVID-19 SelfCheck OTC test
- Adcentrx and AvantGen Enter a New Partnership with a Three-year, Multi-target Collaboration to Discover Antibodies for Novel Antibody-drug Conjugates
- AvantGen receives an award from the NIH/RADx to commercialize its anti-SARS-CoV-2 nucleocapsid antibodies for ultra-high sensitivity lateral flow assay development
- AvantGen Announces Licensing of Its Anti-SARS-CoV-2 Antibodies to IGM Biosciences for COVID-19 Therapy Development
- Avantgen Develops Novel Human Antibodies to Diagnose SARS-COV-2 Infection and Treat COVID-19
- Avantgen Enters a Strategic Collaboration Agreement to Develop Novel Anti-Cancer Therapeutic with Its NK Cell Engager Technology
- Avantgen Appoints Chief Business Officer
- AvantGen And Tanabe Research Laboratories Expand Collaboration For Therapeutic Antibody Discovery
- AvantGen Awarded SBIR Phase II Contract to Develop High-Affinity, Anti-Peptide Rabbit Monoclonal Antibodies for SISCAPA Assays from the NIH/NCI
- AvantGen Awarded SBIR Phase II Grant to Develop High-Affinity Rabbit Monoclonal Antibodies for Neuroscience Related Antigens from the NIH/NIDA